07:00 , Sep 13, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) Meprin Ab (MEP1B) In vitro studies suggest inhibiting MEP1B could help treat AD. In brains from patients with AD, MEP1B levels were...